caffeic acid phenethyl ester has been researched along with 1-methyl-4-phenylpyridinium in 1 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (1-methyl-4-phenylpyridinium) | Trials (1-methyl-4-phenylpyridinium) | Recent Studies (post-2010) (1-methyl-4-phenylpyridinium) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 1,854 | 1 | 593 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| dos Santos, AC; dos Santos, NA; Ferreira, RS; Martins, NM; Silva, Rde B; Sisti, FM | 1 |
1 other study(ies) available for caffeic acid phenethyl ester and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Caffeic acid phenethyl ester (CAPE) protects PC12 cells from MPP+ toxicity by inducing the expression of neuron-typical proteins.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Caffeic Acids; Cell Death; Cell Differentiation; Dose-Response Relationship, Drug; GAP-43 Protein; Nerve Growth Factor; Neurites; Neuroprotective Agents; PC12 Cells; Phenylethyl Alcohol; Rats; Synapsins; Synaptophysin | 2014 |